Getting patients started on KESIMPTA®
(ofatumumab)
Getting patients started on KESIMPTA®
(ofatumumab)
SCREEN
Bloodwork to screen patients for HBV and test their Ig levels1
SHOW
SHOW
Demonstrate KESIMPTA administration using the Sensoready® Demo Pen
START
Start today with samples.* Submit 1-page Start Form
We'll help enroll your patient in Alongside™ KESIMPTA for support and assistance throughout their first year on treatment.
HBV and Ig testing can be added to your patient's regular blood panels
Training pens and videos are provided by Novartis. We can also provide supplemental virtual one-on-one training for your patient
Before initiating KESIMPTA, discuss treatment, including possible side effects like injection reactions, and explain to patients that they start with 1 dose a week for the first 3 weeks, then skip the 4th week before starting once-monthly maintenance dosing
Patients can visit KESIMPTA.com for more details, and may also self-enroll in our Alongside program from the patient site
*Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA.
Personalized support for your patients to start and stay on track with treatment
Dedicated Alongside KESIMPTA Coordinators tailor support so patients are prepared, not overwhelmed
See what else we can help with on the Alongside KESIMPTA page
Patient injection training
Learn how to teach patients to use the Sensoready Pen
A patient-friendly animated training video
Ensure that your patients are getting the coverage and support they need.
Call 1-855-537-4678 for assistance or questions about how to help your patients enroll in Alongside KESIMPTA. Support is available 8:30 AM to 8:00 PM ET, Mon-Fri.
"It was great that I could get started on KESIMPTA right away."
Kristin: mom, real estate agent, KESIMPTA patient
Actual patient taking KESIMPTA who was compensated for time. Individual results may vary.
Support that works with your practice
Everything you need to start patients quickly
Everything you need to start patients quickly
Start today with samples
Start today with samples
KESIMPTA offers a free trial through its sample program to get patients started today.*
Fast start to therapy
Fast start to therapy
80% of eligible patients with commercial insurance start KESIMPTA in 4 days or less through our Bridge Program.2†
93% coverage
93% coverage
The vast majority of commercial lives covered on KESIMPTA.
55% have first-line coverage.3‡
*Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA.
†Based on prescription data collected from April to September 2023.
‡Based on Managed Markets Insight & Technology, LLC database as of November 2023.
Download the KESIMPTA Start Form
Resources to help make KESIMPTA part of your practice
Download Authorization and Appeals Kit
Download Patient Authorization Form
Download Patient Authorization Form (Spanish)
Download Jamie-Lynn's KESIMPTA Story Brochure
See our educational videos about KESIMPTA and the Sensoready Pen
Visit the KESIMPTA Video Library
Templates to help navigate insurance coverage
Download Sample Letter of Appeal - New Treatment
Download Sample Letter of Appeal - Change to Treatment
Download Sample Letter of Medical Necessity - New Treatment
Download Sample Letter of Medical Necessity - Change of Treatment
Visit patient site
Information and resources for treatment with KESIMPTA are available directly to patients. View the KESIMPTA patient site and learn more about these helpful patient services
"I can help people get started on KESIMPTA, from assisting with insurance questions to providing supplemental training on the Sensoready Pen."
Leticia, Alongside Coordinator
HBV, hepatitis B virus; Ig, immunoglobulin; MOA, mechanism of action; MS, multiple sclerosis.